Edward S. Allgeyer, Frederic Pincet, Abdou Rachid Thiam, Maria-Jesus Olarte, Jörg Bewersdorf, Florian Wilfling, Robert V. Farese, Tobias C. Walther, Rainer D. Beck, Travis J. Gould, Jing Wang, Yale School of Medicine [New Haven, Connecticut] (YSM), Laboratoire de Physique Statistique de l'ENS (LPS), Fédération de recherche du Département de physique de l'Ecole Normale Supérieure - ENS Paris (FRDPENS), École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Universität Heidelberg [Heidelberg] = Heidelberg University, Gladstone Institute of Cardiovascular Disease, University of California [San Francisco] (UC San Francisco), University of California (UC), Yale University School of Medicine, Université Paris Diderot - Paris 7 (UPD7)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS)-Fédération de recherche du Département de physique de l'Ecole Normale Supérieure - ENS Paris (FRDPENS), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS), Universität Heidelberg [Heidelberg], University of California [San Francisco] (UCSF), University of California, Allgeyer, Edward [0000-0002-2187-4423], and Apollo - University of Cambridge Repository
Lipid droplets (LDs) are ubiquitous organelles that store neutral lipids, such as triacylglycerol (TG), as reservoirs of metabolic energy and membrane precursors. The Arf1/COPI protein machinery, known for its role in vesicle trafficking, regulates LD morphology, targeting of specific proteins to LDs and lipolysis through unclear mechanisms. Recent evidence shows that Arf1/COPI can bud nano-LDs (∼60 nm diameter) from phospholipid-covered oil/water interfaces in vitro. We show that Arf1/COPI proteins localize to cellular LDs, are sufficient to bud nano-LDs from cellular LDs, and are required for targeting specific TG-synthesis enzymes to LD surfaces. Cells lacking Arf1/COPI function have increased amounts of phospholipids on LDs, resulting in decreased LD surface tension and impairment to form bridges to the ER. Our findings uncover a function for Arf1/COPI proteins at LDs and suggest a model in which Arf1/COPI machinery acts to control ER-LD connections for localization of key enzymes of TG storage and catabolism. DOI: http://dx.doi.org/10.7554/eLife.01607.001, eLife digest Just like the body contains organs that perform different jobs, the cells within the body contain organelles that carry out different tasks. The endoplasmic reticulum, for example, makes proteins that are sent to other organelles or to destinations outside the cell. Each organelle is typically sealed within a membrane made from a double layer of phospholipids—molecules that have a phosphate ‘head’ group at one end, and two fatty acid ‘tails’ at the other. Proteins are shuttled between the organelles inside membrane-bound packages called vesicles. There is, however, an exception to this rule. Lipid droplets are organelles that store fats and oils inside a single layer of phospholipids. This layer can include enzymes that break down the contents of the droplet, or make new fat molecules, depending on the needs of the cell and the organism. However, it is not clear how these enzymes get from the endoplasmic reticulum to the lipid droplet. Previous work had suggested that a protein complex called Arf1/COP—which is also involved in the movement of vesicles around the cell—might recruit the enzymes to the lipid droplets. However, none of the other proteins known to be involved in vesicle transport were needed to transport the enzymes to the droplets, which suggested that the Arf1/COPI complex was using a previously unknown mechanism to move the enzymes. Now Wilfling, Thiam et al. have shown that Arf1/COPI complexes trigger the establishment of membrane bridges between the endoplasmic reticulum and the droplets, which means that vesicles are not needed to get the enyzmes to the lipid droplets. It was also shown that the Arf1/COPI complexes could pinch off tiny droplets from full-size lipid droplets taken from living cells. Wilfling, Thiam et al. suggest that this ‘budding’ process changes the composition of the phospholipid layer around the larger droplet in a way that allows it to interact directly with the membrane of the endoplasmic reticulum. By providing new insights into the trafficking of proteins between organelles, the work of Wilfling, Thiam et al. reveals mechanisms that govern the composition of lipid droplets. In the future, these pathways could be manipulated to treat conditions that result from excessive storage of fat, such as obesity or cardiovascular diseases. DOI: http://dx.doi.org/10.7554/eLife.01607.002